Abstract
We characterized the in vivo cardiovascular profile of SCH 58261, 7-(2-phenylethyl)-5-amino-2-(2-furyl)-pyrazolo-[4,3-e]-1,2,4-triazolo[1,5-c] pyrimidine, a selective A2A adenosine receptor antagonist, in conscious, freely moving rats by use of the telemetry system. In normotensive rats, SCH 58261, at 10 mg/kg i.p., significantly (P < .05) inhibited hypotension and tachycardia induced by the A2A receptor agonist 2-hexynyl-5′-N-ethylcarboxamidoadenosine (0.01 mg/kg i.p.), but not the bradycardic effect caused by the A1 receptor agonist 2-chloro-N6-cyclopentyladenosine (0.03 mg/kg i.p.). SCH 58261, when administered alone, at 0.1 and 1 mg/kg i.p., did not induce significant hemodynamic changes, but at 10 mg/kg i.p., it slightly increased both systolic blood pressure (SBP) and diastolic blood pressure (DBP) (+19 ± 3 and +16 ± 2 mm Hg, respectively; P < .01) and heart rate (HR) (+85 ± 5 beats/min; P < .01). These effects were inhibited by adrenergic blockade with propranolol (30 mg/kg i.p.) and phentolamine (10 mg/kg i.p.): −5 ± 3 mm Hg on DBP and −12 ± 11 beats/min on HR (P < .01). In spontaneously hypertensive rats, SCH 58261, at 3 and 10 mg/kg i.p., increased weakly both SBP (+19 ± 5 mm Hg and +25 ± 4 mm Hg) and DBP (+14 ± 4 mm Hg and +23 ± 4 mm Hg)vs. vehicle (P < .01) and HR (+45 ± 17 and +64 ± 18 beats/min vs. vehicle, respectively; P < .01). The data indicate that SCH 58261 retains A2A selective receptor antagonist properties in vivo. Its effect on cardiovascular sympathetic outflow further suggests that endogenous adenosine exerts a tonic vascular regulation through A2A receptors. Therefore, SCH 58261 can be a useful pharmacological tool for clarifying A2A-mediated cardiovascular actions of adenosine.
Footnotes
-
Send reprint requests to: Angela Monopoli, Schering-Plough Research Institute, San Raffaele Science Park, Via Olgettina 58, I-20132, Milan, Italy.
- Abbreviations:
- SCH 58261
- 7-(2-phenylethyl)-5-amino-2-(2-furyl)-pyrazolo-[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine
- 2HE-NECA
- 2-hexynyl-5′-N-ethylcarboxamidoadenosine
- CCPA
- 2-chloro-N6-cyclopentyladenosine
- BP
- blood pressure
- SBP
- systolic blood pressure
- DBP
- diastolic blood pressure
- HR
- heart rate
- SHRs
- spontaneously hypertensive rats
- NTS
- nucleus tractus solitarius
- DMSO
- dimethyl sulfoxide
- Received May 27, 1997.
- Accepted December 5, 1997.
- The American Society for Pharmacology and Experimental Therapeutics
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|